Paper35775083
Spatial Organization of Osteoclastic Coupling Factors and Their Receptors at Human Bone Remodeling Sites.
Borggaard XG and 4 others. Front Mol Biosci, 2022. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Spatial Organization of Osteoclastic Coupling Factors and Their Receptors at Human Bone Remodeling Sites. Papers, record 35775083. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35775083
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Spatial Organization of Osteoclastic Coupling Factors and Their Receptors at Human Bone Remodeling Sites.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References66
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34332274 | Influences of the IL-6 cytokine family on bone structure and function. | Cytokine | 2021 | https://conductscience.org/library/papers/34332274 | PubMed |
| 2 | 6493035 | Reconstruction of the resorptive site in iliac trabecular bone: a kinetic model for bone resorption in 20 normal individuals. | Metab Bone Dis Relat Res | 1984 | https://conductscience.org/library/papers/6493035 | PubMed |
| 3 | 2170427 | Osteoblasts display receptors for and responses to leukemia-inhibitory factor. | J Cell Physiol | 1990 | https://conductscience.org/library/papers/2170427 | PubMed |
| 4 | 12218157 | IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. | J Immunol | 2002 | https://conductscience.org/library/papers/12218157 | PubMed |
| 5 | 19095960 | A physical mechanism for coupling bone resorption and formation in adult human bone. | Am J Pathol | 2009 | https://conductscience.org/library/papers/19095960 | PubMed |
| 6 | 32919109 | Re-thinking the bone remodeling cycle mechanism and the origin of bone loss. | Bone | 2020 | https://conductscience.org/library/papers/32919109 | PubMed |
| 7 | 26150503 | PDGFB-based stem cell gene therapy increases bone strength in the mouse. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/26150503 | PubMed |
| 8 | 25008556 | Osteoclasts: more than 'bone eaters'. | Trends Mol Med | 2014 | https://conductscience.org/library/papers/25008556 | PubMed |
| 9 | 1717982 | Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. | Proc Natl Acad Sci U S A | 1991 | https://conductscience.org/library/papers/1717982 | PubMed |
| 10 | 2106430 | Leukemia inhibitory factor: a novel bone-active cytokine. | Endocrinology | 1990 | https://conductscience.org/library/papers/2106430 | PubMed |
| 11 | 9799300 | Presentation of six cases of Stüve-Wiedemann syndrome. | Pediatr Radiol | 1998 | https://conductscience.org/library/papers/9799300 | PubMed |
| 12 | 24982128 | EphrinB2 signaling in osteoblasts promotes bone mineralization by preventing apoptosis. | FASEB J | 2014 | https://conductscience.org/library/papers/24982128 | PubMed |
| 13 | 23022498 | Semaphorins in bone development, homeostasis, and disease. | Semin Cell Dev Biol | 2013 | https://conductscience.org/library/papers/23022498 | PubMed |
| 14 | 31689525 | The generation of enlarged eroded pores upon existing intracortical canals is a major contributor to endocortical trabecularization. | Bone | 2020 | https://conductscience.org/library/papers/31689525 | PubMed |
| 15 | 14740318 | Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome. | Am J Hum Genet | 2004 | https://conductscience.org/library/papers/14740318 | PubMed |
| 16 | 8265649 | Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8265649 | PubMed |
| 17 | 18548006 | Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia. | Nature | 2008 | https://conductscience.org/library/papers/18548006 | PubMed |
| 18 | 25395071 | Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment. | Expert Opin Ther Targets | 2015 | https://conductscience.org/library/papers/25395071 | PubMed |
| 19 | 28171762 | Ephs and ephrins. | Curr Biol | 2017 | https://conductscience.org/library/papers/28171762 | PubMed |
| 20 | 19919653 | Myeloma cell-induced disruption of bone remodelling compartments leads to osteolytic lesions and generation of osteoclast-myeloma hybrid cells. | Br J Haematol | 2010 | https://conductscience.org/library/papers/19919653 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42827877 | Reprogramming bone homeostasis: The recoupling-oriented framework of bidirectional regulation strategies for osteoporosis. | iScience | 2026 | https://conductscience.org/library/papers/42827877 | PubMed |
| 42518655 | Biomaterials at the interface of bone-derived factors and inter-organ communication: Current evidence and future perspectives. | Bioact Mater | 2026 | https://conductscience.org/library/papers/42518655 | PubMed |
| 42274574 | The Role of Leukemia Inhibitory Factor in Attenuating Skeletal Muscle Atrophy: Mechanisms to Exercise Interventions. | Cells | 2026 | https://conductscience.org/library/papers/42274574 | PubMed |
| 41566690 | Vildagliptin and Omarigliptin Differentially Bind to DPP-4 Homodimers and Modulate Osteoclast-Mediated Bone Resorption. | Compr Physiol | 2026 | https://conductscience.org/library/papers/41566690 | PubMed |
| 41503151 | Denosumab treatment of osteoporotic women arrests cortical bone remodeling events at the reversal-resorption phase but does not affect ongoing bone formation. | JBMR Plus | 2026 | https://conductscience.org/library/papers/41503151 | PubMed |
| 41339605 | Transcriptome Analysis of Differentially Expressed Genes and Molecular Pathways Involved During Osteoclast Differentiation. | Mol Biotechnol | 2026 | https://conductscience.org/library/papers/41339605 | PubMed |
| 41251183 | Harnessing Advances in Bone Tissue Engineering for Design of Bone-on-Chip Systems. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/41251183 | PubMed |
| 41062856 | Severe Osteoporosis in Larsen Syndrome-A Case Report of Bone Morphology and A Novel Filamin B (FLNB) Variant. | Calcif Tissue Int | 2025 | https://conductscience.org/library/papers/41062856 | PubMed |
| 40924119 | The cellular effect of intermittent PTH treatment on bone remodeling and modeling in humans-a histomorphometry centered scoping review. | Osteoporos Int | 2025 | https://conductscience.org/library/papers/40924119 | PubMed |
| 40797219 | Non-coding RNA modulation in osteoclasts and its implications for osteoblast lineage cell behavior in a co-culture system. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/40797219 | PubMed |
| 40136529 | Mandibular-Derived Monocytes from 1-Year-Old Mice Have Enhanced Osteoclast Differentiation and Differentially Regulated Gene Expression Compared to Femur-Derived Monocytes. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/40136529 | PubMed |
| 39820728 | Decreasing miR-433-3p Activity in the Osteoblast Lineage Blunts Glucocorticoid-mediated Bone Loss. | Endocrinology | 2025 | https://conductscience.org/library/papers/39820728 | PubMed |
| 39424806 | Mapping RANKL- and OPG-expressing cells in bone tissue: the bone surface cells as activators of osteoclastogenesis and promoters of the denosumab rebound effect. | Bone Res | 2024 | https://conductscience.org/library/papers/39424806 | PubMed |
| 38990205 | Osteoclast-derived coupling factors: origins and state-of-play Louis V Avioli lecture, ASBMR 2023. | J Bone Miner Res | 2024 | https://conductscience.org/library/papers/38990205 | PubMed |
| 38591777 | Current perspectives on the multiple roles of osteoclasts: Mechanisms of osteoclast-osteoblast communication and potential clinical implications. | Elife | 2024 | https://conductscience.org/library/papers/38591777 | PubMed |
| 38130746 | Transitory Activation and Improved Transition from Erosion to Formation within Intracortical Bone Remodeling in Hypoparathyroid Patients Treated with rhPTH(1-84). | JBMR Plus | 2023 | https://conductscience.org/library/papers/38130746 | PubMed |
| 36555945 | Bone Modeling after Orthodontic Extrusion: A Histomorphometric Pilot Study. | J Clin Med | 2022 | https://conductscience.org/library/papers/36555945 | PubMed |
Genes24
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35775083
GET https://conductscience.org/api/papers/v1/35775083/references?page=2